Trump plant, FDA-Kommissar Marty Makary zu feuern: WSJ berichtet über politischen Druck und Folgen für die Gesundheits- und Zulassungspolitik

Trump planning to fire FDA Commissioner Marty Makary is reported as part of an escalating political dispute that could reshape U.S. health regulation. The coverage frames the move as pressure on how the FDA handles oversight and approvals, with attention on leadership changes that may affect agency priorities. Regulatory leadership shifts like this can influence enforcement and decision-making across drug and health product safety, potentially altering timelines and expectations for industry and clinicians.